NEW YORK ─ Public Health England researchers are evaluating an Oxford Immunotec test that measures T-cell response to SARS-CoV-2 infection as part of a larger study that aims to also evaluate the potential for coronavirus testing in the home.
On Tuesday, Oxford Immunotec, known best for its tuberculosis tests, announced that it is part of a PHE-sponsored study that involves validating its laboratory-based T-Spot Discovery SARS-CoV-2 test alongside lateral flow immunoassays that are in development.